Pablo Francisco Belaunzarán-Zamudio

15PUBLICATIONS
53CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Behavioural epidemiologyGroundwater quality processes and contaminated land assessmentMedical virologyVeterinary anaesthesiology and intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 18, 2026
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

John R Koethe, Jordan E Lake, Amy Kantor

|Aug 08, 2023
Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trials.

Jessica Mejía-Castrejón, Juan Gerardo Sierra-Madero, Pablo Francisco Belaunzarán-Zamudio

|Jan 04, 2023
Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.

Pablo F Belaunzarán-Zamudio, Lizbeth Naranjo, Yanink Caro-Vega

|Nov 17, 2022
Guillain-Barré syndrome outbreak in Tapachula temporally associated with the Zika virus introduction in Southern Mexico.

Ricardo Paul Rodríguez de la Rosa, J Oggún Cano-Torres, Sonia Rosales

|Aug 29, 2021
Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016-2018): an observational, prospective cohort study.

Pablo F Belaunzarán-Zamudio, Héctor Armando Rincón León, Sandra Caballero Sosa

Pageof 3